App-Quantinova.ai

Successful Treatment with Eculizumab in a Patient with Antiphospholipid Syndrome Presenting with a Thrombotic Storm

J. Nauseef - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Eculizumab

The Prevalence of Criteria and Non‐criteria Antiphospholipid Antibodies in Patients with Unprovoked Venous Thromboembolism

J. Rigano - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

A Well‐defined Subgroup of Chronic Thromboembolic Pulmonary Hypertension Patients Are Positive for Antiphospholipid Antibodies

C.-Y. Cheng - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

Methadone hydrochloride

Plasmatic Oxidative Stress in Patients with Primary Antiphospholipid Syndrome: A Preliminary Study

C. de Oliveira Vaz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Anti‐cardiolipin and Anti‐β2glycoprotein I IgA along with the Current Criteria Does Not Have an Added Value in Screening for Clinical Symptoms of the Antiphospholipid Syndrome

W. Chayoua - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Carbenoxolone sodium

Gene Expression of Tissue Factor and the Risk of Thrombosis Associated with Antiphospholipid Syndrome

B. Mazetto - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Changes in Inflammation and Coagulation Markers in Patients with Thrombotic Primary Antiphospholipid Syndrome Treated with Hydroxychloroquine

F.T. Arantes - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Hydroxychloroquine

Platelet Hemi‐ITAM Signaling Mediated Cancer‐associated Venous Thrombosis Inhibited by a Mononclonal Antibody to Podoplanin, SZ‐168

Y. Zhao - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Influence of P Selectin Glycoprotein Ligand 1 Polymorphisms on the Development of Thrombosis in Myeloproliferative Neoplasm Patients

R. Gerbutavicius - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Procoagulant Platelets as a Diagnostic Predictor of Thrombosis in Lung Cancer Patients

E.E. Ramsay - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Venous thrombosis

N/A

Expression of Von Willebrand Factor by Tumor Cells ‐ Relevance to Cancer‐associated Thrombosis and Animal Studies

Z. Beuchat - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Plasma Factor IXa Activity and HMWK Cleavage Are Elevated in Epithelial Ovarian Cancer: The Role of Intrinsic Coagulation Pathway in Cancer‐associated Thrombosis

P. Tanratana - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Evithrom

Cancer‐associated Thromboembolism: Antithrombotic Management of Patients Hospitalized at an Academic Medical Center

L.K. Golightly - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

dalteparin Subcutaneous

A Comparison of Venous Thromboembolism (VTE) and Arterial Events between Ixazomib, Lenalidomide and Dexamthosone (ILD) and Lenalidomide and Dexamethosone (LD) Chemotherapy in Multiple Myeloma: Single Centre Experience

Z. Sayar - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Lenalidomide

Risk of Upper Limb Venous Thromboembolism from Peripherally Inserted Catheters in Cancer Patients Receiving Chemotherapy

H.L.A. Yuen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Patients with Primary CNS Lymphoma Have High Rates of Venous Thromboembolism during R‐MPV Chemotherapy

H.L.A. Yuen - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methotrexate

Laboratory Measurement of Rivaroxaban Using Anti‐factor Xa Assays in Patients with Cancer‐associated Thrombosis

E.-H. Koh - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

rivaroxaban

Improving Care for Patients with Cancer Associated Thrombosis in the Netherlands Using Patients′, Caregivers′ and Health Care Professionals′ Experiences

A. Jie - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

N/A

Risk of Venous Thromboembolism in Hospitalized Medical Cancer Patients with Midline and Peripherally Inserted Central Catheters

S. Kaatz - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Methadone hydrochloride

Management of Superficial Venous Thrombosis in Unevaluated Situations: Cancer, Severe Chronic Renal Failure, Pregnancy and Post‐partum

L. Ghenassia-Fouillet - Society of Thrombosis and Hemostasis Research (GTH/ISTH) , 2019

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

Filters

7277 Abstracts